ES265597A1 - Un metodo para la preparaciën de un nuevo y util derivado del antibiëtico kanamicina - Google Patents
Un metodo para la preparaciën de un nuevo y util derivado del antibiëtico kanamicinaInfo
- Publication number
- ES265597A1 ES265597A1 ES0265597A ES265597A ES265597A1 ES 265597 A1 ES265597 A1 ES 265597A1 ES 0265597 A ES0265597 A ES 0265597A ES 265597 A ES265597 A ES 265597A ES 265597 A1 ES265597 A1 ES 265597A1
- Authority
- ES
- Spain
- Prior art keywords
- kanamycin
- phenylsalicylate
- solution
- agents
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- ZJWUEJOPKFYFQD-UHFFFAOYSA-N 2-hydroxy-3-phenylbenzoic acid Chemical compound OC(=O)C1=CC=CC(C=2C=CC=CC=2)=C1O ZJWUEJOPKFYFQD-UHFFFAOYSA-N 0.000 title abstract 5
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 title abstract 5
- 229930027917 kanamycin Natural products 0.000 title abstract 4
- 229960000318 kanamycin Drugs 0.000 title abstract 4
- 229930182823 kanamycin A Natural products 0.000 title abstract 4
- 239000000243 solution Substances 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 2
- QPFYXYFORQJZEC-FOCLMDBBSA-N Phenazopyridine Chemical compound NC1=NC(N)=CC=C1\N=N\C1=CC=CC=C1 QPFYXYFORQJZEC-FOCLMDBBSA-N 0.000 abstract 1
- NHUHCSRWZMLRLA-UHFFFAOYSA-N Sulfisoxazole Chemical compound CC1=NOC(NS(=O)(=O)C=2C=CC(N)=CC=2)=C1C NHUHCSRWZMLRLA-UHFFFAOYSA-N 0.000 abstract 1
- 239000004098 Tetracycline Substances 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000001476 alcoholic effect Effects 0.000 abstract 1
- 239000000730 antalgic agent Substances 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000002934 diuretic Substances 0.000 abstract 1
- 229940030606 diuretics Drugs 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000008141 laxative Substances 0.000 abstract 1
- 229940125722 laxative agent Drugs 0.000 abstract 1
- 239000003912 lipotropic agent Substances 0.000 abstract 1
- 229940040504 lipotropic agent Drugs 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 229940100691 oral capsule Drugs 0.000 abstract 1
- 229940096978 oral tablet Drugs 0.000 abstract 1
- 239000007935 oral tablet Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229940125723 sedative agent Drugs 0.000 abstract 1
- 239000000932 sedative agent Substances 0.000 abstract 1
- SKIVFJLNDNKQPD-UHFFFAOYSA-N sulfacetamide Chemical compound CC(=O)NS(=O)(=O)C1=CC=C(N)C=C1 SKIVFJLNDNKQPD-UHFFFAOYSA-N 0.000 abstract 1
- 229960002673 sulfacetamide Drugs 0.000 abstract 1
- VACCAVUAMIDAGB-UHFFFAOYSA-N sulfamethizole Chemical compound S1C(C)=NN=C1NS(=O)(=O)C1=CC=C(N)C=C1 VACCAVUAMIDAGB-UHFFFAOYSA-N 0.000 abstract 1
- 229960002180 tetracycline Drugs 0.000 abstract 1
- 229930101283 tetracycline Natural products 0.000 abstract 1
- 235000019364 tetracycline Nutrition 0.000 abstract 1
- 150000003522 tetracyclines Chemical class 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
- C07C65/105—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
- C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
- C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
- C07H15/234—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14545A US3087858A (en) | 1960-03-14 | 1960-03-14 | Kanamycin 3-phenylsalicylate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES265597A1 true ES265597A1 (es) | 1961-06-01 |
Family
ID=21766097
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES0265597A Expired ES265597A1 (es) | 1960-03-14 | 1961-03-11 | Un metodo para la preparaciën de un nuevo y util derivado del antibiëtico kanamicina |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US3087858A (fr) |
| CH (1) | CH399485A (fr) |
| DE (1) | DE1418658A1 (fr) |
| ES (1) | ES265597A1 (fr) |
| FR (2) | FR1459717A (fr) |
| GB (1) | GB903162A (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3156617A (en) * | 1962-04-05 | 1964-11-10 | Bristol Myers Co | Therapeutic compositions of kanamycin 2-(para-tertiary-amylphenoxy)-n-butyrate |
| US3342687A (en) * | 1964-06-25 | 1967-09-19 | Colgate Palmolive Co | Oral preparation |
| US4911924A (en) * | 1987-04-17 | 1990-03-27 | University Of New Mexico | Induction of antibiotic hypersensitivity in tetracycline-resistance microorganisms |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2870138A (en) * | 1953-08-13 | 1959-01-20 | Upjohn Co | Erythromycin salts |
| US2931798A (en) * | 1956-09-05 | 1960-04-05 | Umezawa Hamao | Kanamycin and processes for the preparation thereof |
-
1960
- 1960-03-14 US US14545A patent/US3087858A/en not_active Expired - Lifetime
-
1961
- 1961-02-28 CH CH240061A patent/CH399485A/de unknown
- 1961-02-28 GB GB7332/61A patent/GB903162A/en not_active Expired
- 1961-03-08 DE DE19611418658 patent/DE1418658A1/de active Pending
- 1961-03-11 ES ES0265597A patent/ES265597A1/es not_active Expired
- 1961-03-13 FR FR855463A patent/FR1459717A/fr not_active Expired
- 1961-06-07 FR FR864190A patent/FR1184M/fr active Active
Also Published As
| Publication number | Publication date |
|---|---|
| FR1184M (fr) | 1962-03-12 |
| GB903162A (en) | 1962-08-15 |
| FR1459717A (fr) | 1966-06-17 |
| DE1418658A1 (de) | 1969-01-09 |
| US3087858A (en) | 1963-04-30 |
| CH399485A (de) | 1965-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES370058A1 (es) | Procedimiento para la preparacion de composiciones farma- ceuticas efervescentes. | |
| ES265597A1 (es) | Un metodo para la preparaciën de un nuevo y util derivado del antibiëtico kanamicina | |
| ES378247A1 (es) | Procedimiento para la obtencion de derivados del acido tio-carbamico. | |
| IL46725A (en) | 4-o(2',6'-diamino-2',3',4',6'-tetra-desoxy-alpha d-erythrohexopyrannosyl)6-o-3"-methylamino-3",4",6"-tridesoxy alpha d-xylohexopyrannosyl)-2-desoxystreptamine and its salts and process of preparation and pharmaceutical compositions | |
| ES377523A1 (es) | Un procedimiento para fabricar una sustancia combinada, compuesta de acido germanico y cisteina. | |
| BE792803A (fr) | Derives d'acide 8,12-diisoprostanoique optiquement actifs, leurpreparation et compositions en contenant | |
| IL34468A0 (en) | Acid addition salts of indenopyridine derivatives,their preparation and pharmaceutical compositions containing them | |
| ES368399A1 (es) | Procedimiento para la preparacion de nuevos 1-fenoxi-2-hi- droxi - 3-ter-butilamino propanos sustituidos. | |
| GB1287433A (en) | Pharmaceutical compositions | |
| GB1019111A (en) | Salts of 5-amino-isoindoline | |
| GB1299037A (en) | Dithiocarbamic acid esters | |
| IL40623A (en) | 14,15-dihydro-eburnamine-14-carboxylic acid derivatives and salts thereof,their preparation and pharmaceutical compositions containing them | |
| GB1418019A (en) | Antimicrobial compositions | |
| FR1416M (fr) | Médicament a base d'acide n-(2,6-diméthyl-3-chlorophényl)-anthranilique, utile pour combattre des états inflammatoires. | |
| GB1045969A (en) | Sodium betaine aspartate | |
| ES293574A1 (es) | Procedimiento de preparaciën del glucoheptonato de hierro | |
| IL36985A (en) | Pharmaceutical compositions containing acid addition salts of benzyl-(or beta-phenylethyl)-dimethylguanidine,certain such novel salts and their preparation | |
| IL39888A (en) | Heterocyclic-substituted xanthone carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them | |
| CA783080A (en) | Carboxylic acid amides, preparation thereof and anthelmintic pharmaceutical compositions | |
| GB908634A (en) | Pharmaceutical compositions containing pararosaniline or derivatives thereof | |
| GB993601A (en) | Antiviral compositions comprising adenine derivatives | |
| CA957373A (en) | Salts of para-chlorophenoxyisobutyric acid, their preparation and pharmaceutical compositions containing them | |
| CA820860A (en) | Pharmaceutical composition containing the hydrochloric acid addition salt of 2-amino-adamantane as active ingredient | |
| GB544836A (en) | Improvements relating to the preparation of sulphonamide compounds | |
| ES267391A1 (es) | Un procedimiento para la preparaciën de compuestos antipatëgenos |